Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Peptide regulation stories

Oct 28, 2026

HHS allows temporary compounding of six unapproved peptides

The Department of Health and Human Services announced a policy permitting compounding pharmacies to temporarily produce six peptides that have not yet been approved by FDA, advancing access to controversial wellness compounds while permanent regulations are developed.

Oct 28, 2026·5 sources
00
Jun 25, 2026

Supreme Court Blocks Thousands of Lawsuits Against Bayer Over Roundup Cancer Claims

The U.S. Supreme Court ruled 7-2 in favor of Bayer's Monsanto division, blocking thousands of state-level lawsuits alleging the company failed to warn consumers that Roundup weedkiller could cause cancer. The decision establishes that federal pesticide labeling law preempts state liability claims.

Jun 25, 2026·9 sources
00

Top claims

  • ▪The Department of Health and Human Services stated its enforcement discretion policy aims to discourage the widespread use of research-use-only peptides supplied by foreign manufacturers that present safety risks to U.S. patients
  • ▪In July 2026, a majority of external advisers on the Food and Drug Administration's Pharmacy Compounding Advisory Committee voted in favor of expanding availability for six peptides, despite agency staff findings of insufficient safety and efficacy evidence
  • ▪The Department of Health and Human Services limited enforcement discretion to temporarily allow compounding pharmacies, federal facilities, and licensed physicians to manufacture and sell six unapproved peptides: BPC-157, TB-500, Epitalon, KPV, MOTS-c, and Semax

People involved

Robert F. Kennedy Jr.

Subtopics

Government and Regulatory Policy2BPC-1571Compounding pharmacies1Consumer protection1Drug Approval and Clinical Trials1Drug Policy, Pricing & Approval1Environmental regulations1Epithalon1FDA regulation1Federal preemption1Healthcare fraud & litigation1MOTS-c1Peptide therapy1Peptide Therapy Safety1Peptides & Emerging Supplement Trends1Product liability law1Regulatory compliance1U.S. policy & law1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories